Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	146.79B
Revenue (ttm)	15.54B
Net Income (ttm)	1.38B
Shares Out	207.99M
EPS (ttm)	7.33
PE Ratio	96.27
Forward PE	75.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	444,199
Average Volume	495,953
Open	733.00
Previous Close	734.30
Day's Range	696.15 - 739.90
52-Week Range	639.15 - 808.80
Beta	n/a
RSI	51.86
Earnings Date	Feb 6, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Commercial Physical and Biological Research
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2023, Sai Life Sciences's revenue was 14.65 billion, an increase of 20.38% compared to the previous year's 12.17 billion. Earnings were 828.09 million, an increase of 729.00%.